Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User
Not Applicable
Completed
- Conditions
- Alcohol DependenceDrug Dependence,Substance Use Disorder
- Registration Number
- NCT02173041
- Lead Sponsor
- Macmillan Research Group UK
- Brief Summary
Substance Use Disorder has been showing a rising trend all over the world including India. The project tested whether a Integrated community wide effort of Prevention and Awareness Groups (PAG) to manage substance use would have a greater effect on treatment attendance and drug abstinence than a de-addiction program alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 152
Inclusion Criteria
- suburban, rural Population
- Drug and/or alcohol dependency (DSM-IV substance use disorders criteria)
Exclusion Criteria
- Did not consent to participate
- Planning to move or relocate
- Severe mental disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Treatment attendance Change from baseline to six month
- Secondary Outcome Measures
Name Time Method Drug abstinence Change from baseline to six month
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of Prevention Awareness Groups (PAG) in reducing substance use disorder relapse rates?
How does the PAG intervention compare to standard-of-care de-addiction programs in improving treatment adherence for alcohol and drug dependence?
Are there specific biomarkers associated with enhanced response to community-based prevention strategies in patients with opioid or stimulant use disorders?
What adverse events are commonly reported in substance use disorder trials using non-pharmacological interventions like PAG, and how are they managed?
What combination therapies or pharmaceutical agents show synergistic effects with community awareness programs in treating co-occurring substance use and mental health disorders?
Trial Locations
- Locations (1)
GyanSanjeevani
🇮🇳Bai, Nawalgarh, Rajasthan, India
GyanSanjeevani🇮🇳Bai, Nawalgarh, Rajasthan, India